Loss of heterozygosity at the mannose 6-phosphate insulin-like growth factor 2 receptor (M6P/IGF2R) locus predisposes patients to radiation-induced lung injury
- 1 January 2001
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 49 (1), 35-41
- https://doi.org/10.1016/s0360-3016(00)01377-8
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Elevated Plasma Transforming Growth Factor-β1 Levels in Breast Cancer Patients Decrease After Surgical Removal of the TumorAnnals of Surgery, 1995
- Elevated plasma levels of TGF-β1 in patients with invasive prostate cancerNature Medicine, 1995
- Plasma transforming growth factor-β1 in patients with hepatocellular carcinoma. Comparison with chronic liver diseasesCancer, 1994
- Effect of antibody to transforming growth factor beta on bleomycin induced accumulation of lung collagen in mice.Thorax, 1993
- Elevated Levels of Plasma Transforming Growth Factor‐β in Patients with Hepatocellular CarcinomaJapanese Journal of Cancer Research, 1992
- TGF-β: Regulation of extracellular matrixKidney International, 1992
- Cellular activation of latent transforming growth factor beta requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor type II receptor.Proceedings of the National Academy of Sciences, 1991
- The Transforming Growth Factor-beta FamilyAnnual Review of Cell Biology, 1990
- Transforming Growth Factor-β1 Expression in Irradiated LiverRadiation Research, 1990
- Transforming growth factor-beta. Multiple actions and potential clinical applicationsJAMA, 1989